Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Edith Ho joined Stanford University in February of 2020, where she currently holds the position of Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology. She specializes in the diagnosis and treatment of inflammatory bowel disease and also practices general gastroenterology. Previously, she joined faculty at Case Western Reserve School of Medicine as Assistant Professor of Medicine. She served as a gastroenterologist at the Cleveland Veterans Affairs Medical Center, where she was Director of the Inflammatory Bowel Disease Program. She was also the Co-Director of the Fecal Microbiota Transplantation Program, where she was lauded as the pioneer of the first fecal transplant program in the U.S. veterans affairs healthcare system nationwide.Dr. Ho is a Diplomate of the American Board of Internal Medicine (ABIM) and the American Board of Gastroenterology, a Fellow of the American College of Gastroenterology (FACG), and a Fellow of the American Gastroenterological Association (AGAF). She serves on the Educational Affairs Committee of ACG where she chairs several abstract committees, directs regional post-graduate courses, and develops CME content for the American Journal of Gastroenterology. She also serves on the AGA Institute Clinical Guidelines Committee as a panel member and guideline author.
Dr. Ho plays an active role in the American College of Gastroenterology (ACG) Educational Affairs committee, where she chairs several abstract committees, directs regional post-graduate courses, regularly reviews physician course content, and develops CME content for the American Journal of Gastroenterology. She also serves as a guideline author for the American Gastroenterological Association on endoscopic therapies for weight loss and the medical management of luminal and perianal Crohn's disease. These guidelines shed new knowledge and set new standards of care for clinical practice here and abroad. Dr. Ho’s research interests include investigating screening practices prior to initiating immunosuppressive therapy, and non-traditional therapies for inflammatory bowel disease.